SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil

ABSTRACT Reinfection by the severe acute respiratory syndrome coronavirus type 2 (SARS-COV-2) has been reported in many countries, suggesting that the virus may continue to circulate among humans despite the possibility of local herd immunity due to massive previous infections. The emergence of variants of concern (VOC) that are more transmissible than the previous circulating ones has raised particular concerns on the vaccines effectiveness and reinfection rates. The P.1 lineage was first identified in December 2020 in Manaus city and is now globally spread. We report the first case of reinfection of SARS-CoV-2 caused by the P.1 variant outside of Manaus. The potential of these new variants to escape naturally and vaccine- induced immunity highlights the need for a global vigilance.

[1]  Davey M. Smith,et al.  Sensitive immunodetection of SARS-CoV-2 variants-of-concern 501Y.V2 and 501Y.V1 , 2021, The Journal of infectious diseases.

[2]  K. Mølbak,et al.  Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study , 2021, The Lancet.

[3]  A. Iafrate,et al.  Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity , 2021, Cell.

[4]  D. Fremont,et al.  Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies , 2021, Nature Medicine.

[5]  Nuno R. Faria,et al.  Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil , 2021, medRxiv.

[6]  Joshua B. Singer,et al.  Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study , 2021, The Lancet. Public health.

[7]  Nuno R. Faria,et al.  Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, December 2020 , 2021, Emerging infectious diseases.

[8]  Chris Stokel-Walker What we know about covid-19 reinfection so far , 2021, BMJ.

[9]  A. Charlett,et al.  Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020 , 2021, medRxiv.

[10]  D. Stuart,et al.  Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers , 2020, The New England journal of medicine.

[11]  E. Soutschek,et al.  The serological response to SARS corona virus-2 is characterized by frequent incomplete maturation of functional affinity (avidity) , 2020 .

[12]  H. Goossens,et al.  Seasonal coronavirus protective immunity is short-lasting , 2020, Nature Medicine.

[13]  P. Maes,et al.  Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  K. To,et al.  COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Nuno R. Faria,et al.  Importation and early local transmission of COVID-19 in Brazil, 2020 , 2020, Revista do Instituto de Medicina Tropical de Sao Paulo.

[16]  Olivier Gascuel,et al.  PHYML Online: A Web Server for Fast Maximum Likelihood-Based Phylogenetic Inference , 2018 .